{"count": 1, "results": [{"_id": "6745087", "pmid": 6745087, "title": "Propranolol-induced psychosis.", "journal": "Drug Intell Clin Pharm", "authors": ["McGahan DJ", "Wojslaw A", "Prasad V", "Blankenship S"], "date": "1984-07-01T00:00:00Z", "doi": "10.1177/106002808401800709", "meta_date_publication": "1984 Jul-Aug", "meta_volume": "18", "meta_issue": "7-8", "meta_pages": "601-3", "score": 50066.05, "text_hl": "However, @DISEASE_Apraxias @DISEASE_MESH:D001072 @@@paranoid ideations@@@, illusions, severe combativeness, and @DISEASE_Hallucinations @DISEASE_MESH:D006212 @@@visual hallucinations@@@ developed shortly after initiation of the listed therapy. When @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ was substituted for @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@, all @<m>DISEASE_Psychotic_Disorders</m> @DISEASE_MESH:D011618 @@@psychotic behavior@@@ resolved.", "citations": {"NLM": "McGahan DJ, Wojslaw A, Prasad V, Blankenship S. Propranolol-induced psychosis. Drug Intell Clin Pharm. 1984 Jul-Aug;18(7-8):601-3. PMID: 6745087", "BibTeX": "@article{6745087, title={Propranolol-induced psychosis.}, author={McGahan DJ and Wojslaw A and Prasad V and Blankenship S}, journal={Drug Intell Clin Pharm}, volume={18}, number={7-8}, pages={601-3}}"}}]}